Clinical Trial

Pain, Sleep Quality, Eating Habits and Physical Activity Level in Patients With Bipolar Disorder

Completed
View on ClinicalTrials.gov →
Summary
Bipolar disorder (BD) is a complex condition characterized by recurrence of mania, hypomania, and depression. It is characterized by changes in daily life activities, sleep status, focus problems, and cognitive fluctuations. The mortality rate due to suicide and cardiovascular diseases increases in individuals with BD. The DSM-5TR defines BD as Bipolar I Disorder (BD-1) with one or more manic episodes, Bipolar II Disorder (BD-II) with at least one severe depressive episode accompanied by at least one hypomanic episode, Cyclothymia disorder, substance-induced bipolar disorder, bipolar or related disorder related to another medical condition, other defined bipolar and related disorder, and undefined bipolar and related disorder. The lifetime prevalence of BD varies between 0.6% and 1.0% for Type I and 0.4% and 1.1% for Type II. Symptoms usually start between 14-21 years of age. Depressive episodes and lifelong single marital status are more common in females, while substance abuse is more common in males. Depression attacks are longer than manias, but the duration of attacks does not differ between types. The mean duration of depressive and manic periods is 5.2 months and 3.5 months, respectively. Pain is observed in 28.9% of patients with a diagnosis of GI, which decreases the quality of life and is a significant concern in psychological disorders.
Protocol Amendment History 2 changes
critical Trial status changed: Enrolling by Invitation → Completed 2026-08-05
notable Enrollment reduced: 50 -> 34 participants 2026-08-05
Trial Details
NCT Number NCT06954350
Lead Sponsor Kutahya Health Sciences University
Conditions Bipolar Disorder (BD)
Enrollment 34 participants
Start Date 2025-02-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-04